Central Admixture Pharmacy Services Inc: Drug Recall

Recall #D-0015-2024 · 09/21/2023

Class II: Risk

Recall Details

Recall Number: D-0015-2024
Classification: Class II
Product Type: Drug
Recalling Firm: Central Admixture Pharmacy Services Inc
Status: Terminated
Date Initiated: 09/21/2023
Location: San Diego, CA, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 895 50 mL syringes

Reason for Recall

Lack of assurance of sterility:

Product Description

fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 50 mL, Total fentaNYL 75 mcg/50 mL, 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2080-2

Distribution Pattern

Nationwide in the USA

Other Recalls by Central Admixture Pharmacy Services Inc

Class I: Dangerous 02/20/2025

Presence of Particulate Matter
Class II: Risk 09/21/2023

Lack of assurance of sterility:
Class II: Risk 09/21/2023

Lack of assurance of sterility:
Class II: Risk 09/21/2023

Lack of assurance of sterility:
Class II: Risk 09/21/2023

Lack of assurance of sterility:

View all recalls by Central Admixture Pharmacy Services Inc →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.